Ongue, Alonah C.
HRN: 22-95-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/24/2023
04/25/2023
IV
500mg
Now Then Q8hrs X 2 More Doses
S/P NSVD With 4th Degree Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes